Your browser doesn't support javascript.
loading
Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma.
Viswabandya, Auro; Shah, Sandip; Mukhopadhyay, Asis; Nagarkar, Rajnish Vasant; Batra, Sonica Sachdeva; Lopez-Lazaro, Luis; Kankanwadi, Suresh; Srivastava, Alok.
Affiliation
  • Viswabandya A; Christian Medical College, Vellore, India.
  • Shah S; Vedanta Institute of Medical Sciences, Ahmedabad, India.
  • Mukhopadhyay A; Netaji Subhash Chandra Bose Cancer Research Institute, Kolkata, India.
  • Nagarkar RV; Curie Manavata Cancer Centre, Nashik, India.
  • Batra SS; Dr Reddy's Laboratories, Hyderabad, India.
  • Lopez-Lazaro L; Dr Reddy's Laboratories, Basel, Switzerland.
  • Kankanwadi S; Dr Reddy's Laboratories, Basel, Switzerland.
  • Srivastava A; Christian Medical College, Vellore, India.
J Glob Oncol ; 5: 1-13, 2019 11.
Article in En | MEDLINE | ID: mdl-31809224
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Biosimilar Pharmaceuticals / Rituximab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Glob Oncol Year: 2019 Document type: Article Affiliation country: India Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Biosimilar Pharmaceuticals / Rituximab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Glob Oncol Year: 2019 Document type: Article Affiliation country: India Country of publication: United States